Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
ACR Appropriateness Criteria® Staging and Follow-Up of Pancreatic Neuroendocrine Tumors.
Journal: Journal of the American College of Radiology : JACR
Published: February 04, 2026
Characterization of small intestinal neuroendocrine tumorlets.
Journal: Endocrine-related cancer
Published: October 23, 2025
Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy.
Journal: Endocrine pathology
Published: September 13, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 03, 2025
Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided management.
Journal: Insights into imaging
Published: July 14, 2025
Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 10, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Journal: JCO oncology practice
Published: May 09, 2025
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients With Metastatic Neuroendocrine Tumors: A Prospective Study.
Journal: AJR. American journal of roentgenology
Published: April 16, 2025
Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational study.
Journal: Therapeutic advances in medical oncology
Published: March 04, 2025
Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus.
Journal: Surgical endoscopy
Published: February 03, 2025
Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies.
Journal: JCO precision oncology
Published: November 07, 2024
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53.
Journal: Endocrine pathology
Published: October 22, 2024
Last Updated: 09/26/2026